Novozymes today inaugurates the newest expansion of its Hongda production facility in Taicang, China, making it the largest enzyme fermentation facility in the world.
The facility, Suzhou Hongda Enzymes Co., is located in Taicang, Suzhou,
Jiangsu Province, about 50 km north of Shanghai. The expanded capacity will
primarily focus on products for the bioethanol industry, with the expansion
signaling an investment in both bioethanol and the expanding Chinese
market.
Peder Holk Nielsen,
Executive Vice President of Novozymes A/S, says: “We believe bioethanol is a
good example how biotechnology can make more from less, decoupling economic
growth from the use of natural resources.
Novozymes is optimistic about the future of
bioethanol and is dedicated to increasing our capabilities continuously in this
field. The Suzhou facility is one of Novozymes’ strategic manufacturing
locations, and this new expansion will enable us to accomplish
more.”
Related website:
Novozymes